A twice-yellow injectable drug for the prevention of HIV infection has been approved by the United States’ Food and Drug Administration. With better compliance expected – Instad of Daily pills on a shot every two months that people have to take at the moment – it is one of the most anticipated developments in the true of hib prevent.

The Lenacapavir Injection – Sold as Yeztugo by Pharmaceutical Giant Gilead – was approved based on the result of two phase 3 trils that showed 99.9% of individuals remained HIVE Annually. “FDA Approval … paves the way for who prequalification, which can accept national regulatory approvals … and procurement by donor agencies Key Barriers Such As Daily Pill Burden, Frequent Clinic Visits and Stigma Associated with HIV Prevention, “The World Health Organization (WHO) Said.

What is Lenacapavir?

Lenacapavir is an anti-rTroviral medication that can be used to treat as well as prevent hiv. As Sunlenca, it is used in combination with other antiretroviral drugs for the treatment of people who have been on pills for a very long time and are resistant to multiple drugs. As yesstugo, it is a pre-interiosure prophylaxis (prep) to prevent the infection.

Story Continues Below this ad

The drink work by binding with the HIV capsid – a protein shell that protects the virus’ genetic material. It is then disrupts cruc steps needed for the virus to replicate and infect new cells.

What is prep?

Prep or inter-interosure prophylaxis is a drug or injectable meant to prevent HIV infection in people at a high risk of contracting the disease. These Medicines can redeuce the risk of acquiring hiv infection through sexual activity by 99% and through injection drug use by 74%.

At present, there are several types of prep available – pills such as truvada or descovy, dapivirine vaginal ring and the injectable cabotegravir that has to be taken egy two months.

It is important to be tested for HIV before taking prep. While these medicines are also used in the treatment of HIV, they are prescribed in combination with other antiretrovirals. Given alone to a patient with HIV, they Might Developed Resistance to the drugs.

Story Continues Below this ad

WHO needs prep?

Prep is usually recommended for people living with an HIV positive partner, those who frequently changed partners, those who have sex with people with Unknownown Hiv Status, Those who work in the sex. Injectable drugs. Medicines for post exposure prophylaxis are also available to be used as an Emergency Measure in Cases Such as Inadvertal exposure in a Hospital Setting, After Condom Failure, OR During SEXUAL.

Is prep available in India?

While generic versions of the prep pills are approved in India-Cabotegravir injection is also available through a sub-watering contraction-they are not widly used.

This is mainly owing to the cost of the media and the fact that they are not yet part of the country’s national program, which already provides life-Life-Long Treatment to all who has dialized. The New Injectable Will Cost USD 28,218 Annually, remaining out of reach for many.

Even in the us, usage remains low. Only 36% of the 1.2 Million People who will have benefited from the medicine was prescribed it.

Annona Dutt

Anonna Dutt is a principal correspondent who writes primarily on health at the Indian express. She Reports on Myriad Topics Ranging from the growing burden of non-compromunicable diseases such as diabetes and hypertension to the problem with pervasive infectious conditions. She Reported on the Government’s Management of the Covid-19 Pandmic and Closely followed the Vaccination Program. Her stories have results in the city government investing in high-end tests for the poore and acknowledging errors in their official reports. Dutt also take a keeps in the country’s space program and has written on key missions like Chandrayaan 2 and 3, Aditya L1, and Gaganyaan. She was Among the first batch of Eleven Media Felows with RBM Partnership to End Malaria. She was also selected to participle in the short-trm program on Early Childhood Reporting at Columbia University’s Dart Center. Dutt has a bachelor’s degree from the Symbiosis Institute of Media and Communication, Pune and A PG Diploma from the asian college of journalism, chennai. She started her reporting career with the hindustan times. When not at work, she tries to appease the duolingo owl with her freench skills and sometimes take to the dance floor. … Read more

© The Indian Express PVT LTD